|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005064,
umls-concept:C0022860,
umls-concept:C0034656,
umls-concept:C0189391,
umls-concept:C0242402,
umls-concept:C0355642,
umls-concept:C0445202,
umls-concept:C0599724,
umls-concept:C0599946,
umls-concept:C0600097,
umls-concept:C0677582,
umls-concept:C0814225,
umls-concept:C0871261,
umls-concept:C1274040,
umls-concept:C1524062,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2008-6-13
|
|
pubmed:abstractText |
Hypertension and tachycardia are common during fiber-optic bronchoscopy (FOB), and this may lead to cardiac ischemia. The prophylactic addition of a beta-adrenergic anatagonist might mask this response and prevent the deleterious cardiovascular effects of FOB.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0954-6111
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
102
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
978-83
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:18394874-Adrenergic beta-Antagonists,
pubmed-meshheading:18394874-Alfentanil,
pubmed-meshheading:18394874-Analgesics, Opioid,
pubmed-meshheading:18394874-Antihypertensive Agents,
pubmed-meshheading:18394874-Benzodiazepines,
pubmed-meshheading:18394874-Blood Pressure,
pubmed-meshheading:18394874-Bronchoscopy,
pubmed-meshheading:18394874-Double-Blind Method,
pubmed-meshheading:18394874-Drug Therapy, Combination,
pubmed-meshheading:18394874-Female,
pubmed-meshheading:18394874-Fiber Optic Technology,
pubmed-meshheading:18394874-Heart Rate,
pubmed-meshheading:18394874-Humans,
pubmed-meshheading:18394874-Hypertension,
pubmed-meshheading:18394874-Hypnotics and Sedatives,
pubmed-meshheading:18394874-Labetalol,
pubmed-meshheading:18394874-Male,
pubmed-meshheading:18394874-Midazolam,
pubmed-meshheading:18394874-Middle Aged,
pubmed-meshheading:18394874-Monitoring, Ambulatory,
pubmed-meshheading:18394874-Optical Fibers,
pubmed-meshheading:18394874-Sympathetic Nervous System,
pubmed-meshheading:18394874-Tachycardia,
pubmed-meshheading:18394874-Treatment Failure
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Benzodiazepine and opioid sedation attenuate the sympathetic response to fiberoptic bronchoscopy. Prophylactic labetalol gave no additional benefit. Results of a randomized double-blind placebo-controlled study.
|
|
pubmed:affiliation |
Pulmonary Institute, Rabin Medical Center (Beilison Campus), Petach Tikva, Israel. foxb@clalit.org.il
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
